The U.S. Supreme Court allowed a lower-court ruling to stand that lets insurers collect double damages from drugmakers under Medicare Advantage plans. GlaxoSmithKline had argued that the Medicare Advantage program does not allow insurers administering plans to press liability cases.
Supreme Court rejects Glaxo's appeal in Avandia case
SmartBrief Job Listings for Health Care
|Compliance and Ethics Director||
Sysmex America, Inc.
|Director, Site Quality Management||
|Palm Springs, CA|
|Compliance Officer-Medical Products||
W. L. Gore